1. Home
  2. CRMD vs KTWO Comparison

CRMD vs KTWO Comparison

Compare CRMD & KTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$6.61

Market Cap

509.9M

Sector

Health Care

ML Signal

HOLD

KTWO

K2 Capital Acquisition Corporation Class A Ordinary Share

N/A

Current Price

$9.87

Market Cap

431.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CRMD
KTWO
Founded
2006
2025
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
509.9M
431.2M
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
CRMD
KTWO
Price
$6.61
$9.87
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.4M
99.2K
Earning Date
03-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
780.00
N/A
EPS
2.04
N/A
Revenue
$311,709,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.17
N/A
Revenue Growth
617.03
N/A
52 Week Low
$5.60
$9.84
52 Week High
$17.43
$9.89

Technical Indicators

Market Signals
Indicator
CRMD
KTWO
Relative Strength Index (RSI) 43.67 49.71
Support Level $6.55 N/A
Resistance Level $7.44 $9.89
Average True Range (ATR) 0.24 0.01
MACD 0.05 -0.00
Stochastic Oscillator 58.83 60.00

Price Performance

Historical Comparison
CRMD
KTWO

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: